The Changing Policy and Communications Environment and Implications for Pharma Marketing, Part 2

Today please find the second in a three-part series that looks at the changing policy and communications environments and the challenges and opportunities for pharmaceutical marketing.  In Part 1 yesterday, what was covered was the fact that there is a growing possibility of a double pincer type movement – one arm that will likely curtail DTC advertising to consumers and a second that will likely dilute the kinds of relationships that industry has with practicing medicine.  Either of these alone might have a big impact on pharma marketing, together that is ensured.